A549 Alveolar Carcinoma Spheroids As a Cytotoxicity Platform for Carboxyl- and Amine-Polyethylene Glycol Gold Nanoparticles

Overview

Journal Pharmacol Res Perspect

Date 2024 Dec 26

PMID 39725610

Authors

Melissa Petzer

Seth-Frerich Fobian

Mary Gulumian

Vanessa Steenkamp

Werner Cordier

Affiliations

Soon will be listed here.

Abstract

Gold nanoparticles (AuNPs) present with unique physicochemical features and potential for functionalization as anticancer agents. Three-dimensional spheroid models can be used to afford greater tissue representation due to their heterogeneous phenotype and complex molecular architecture. This study developed an A549 alveolar carcinoma spheroid model for cytotoxicity assessment and mechanistic evaluation of functionalized AuNPs. A549 spheroids were generated using an agarose micro-mold and were characterized (morphology, acid phosphatase activity, protein content) over 21 culturing days. The 72-h cytotoxicity of carboxyl-polyethylene glycol- (PCOOH-) and amine-polyethylene glycol- (PNH-) functionalized AuNPs against Day 7 spheroids was assessed by determining spheroid morphology, acid phosphatase activity, protein content, caspase-3/7 activity, and cell cycle kinetics. Spheroids remained stable over the experimental period. Although the A549 spheroids' volume increased while remaining viable over the culturing period, structural integrity decreased from Day 14 onwards. The PCOOH-AuNPs lacked cytotoxicity at a maximum concentration of 1.2 × 10 nanoparticles/mL with no prominent alteration to the cellular processes investigated, while the PNH-AuNPs (at a maximum of 4.5 × 10 nanoparticles/mL) displayed dose- and time-dependent cytotoxicity with associated loss of spheroid compactness, debris formation, DNA fragmentation, and a 75% reduction in acid phosphatase activity. Differentiation between cytotoxic and non-cytotoxic AuNPs was achieved, with preliminary elucidation of cytotoxicity endpoints. The PNH-AuNPs promote cytotoxicity by modulating cellular kinetics while destabilizing the spheroid ultrastructure. The model serves as a proficient platform for more in-depth elucidation of NP cytotoxicity at the preclinical investigation phase.

References

Lu H, Stenzel M . Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles. Small. 2018; 14(13):e1702858. DOI: 10.1002/smll.201702858. View

Coulter J, Jain S, Butterworth K, Taggart L, Dickson G, McMahon S . Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles. Int J Nanomedicine. 2012; 7:2673-85. PMC: 3373299. DOI: 10.2147/IJN.S31751. View

Montes-Fonseca S, Orrantia-Borunda E, Aguilar-Elguezabal A, Gonzalez Horta C, Talamas-Rohana P, Sanchez-Ramirez B . Cytotoxicity of functionalized carbon nanotubes in J774A macrophages. Nanomedicine. 2011; 8(6):853-9. DOI: 10.1016/j.nano.2011.10.002. View

Geetha R, Ashokkumar T, Tamilselvan S, Govindaraju K, Sadiq M, Singaravelu G . Green synthesis of gold nanoparticles and their anticancer activity. Cancer Nanotechnol. 2015; 4(4-5):91-98. PMC: 4451866. DOI: 10.1007/s12645-013-0040-9. View

Friedman A, Claypool S, Liu R . The smart targeting of nanoparticles. Curr Pharm Des. 2013; 19(35):6315-29. PMC: 4016770. DOI: 10.2174/13816128113199990375. View

Sun F, Hu Y, Xiong L, Tu X, Zhao J, Chen S . Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells. Int J Clin Exp Pathol. 2015; 8(6):6287-300. PMC: 4525839. View

Kumar S . Caspase function in programmed cell death. Cell Death Differ. 2006; 14(1):32-43. DOI: 10.1038/sj.cdd.4402060. View

Chiarugi P, Giannoni E . Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol. 2008; 76(11):1352-64. DOI: 10.1016/j.bcp.2008.07.023. View

Norde W, Gage D . Interaction of bovine serum albumin and human blood plasma with PEO-tethered surfaces: influence of PEO chain length, grafting density, and temperature. Langmuir. 2005; 20(10):4162-7. DOI: 10.1021/la030417t. View

10.

de Jong W, Borm P . Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine. 2008; 3(2):133-49. PMC: 2527668. DOI: 10.2147/ijn.s596. View

11.

Paoli P, Giannoni E, Chiarugi P . Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013; 1833(12):3481-3498. DOI: 10.1016/j.bbamcr.2013.06.026. View

12.

Shvedova A, Castranova V, Kisin E, Schwegler-Berry D, Murray A, Gandelsman V . Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A. 2003; 66(20):1909-26. DOI: 10.1080/713853956. View

13.

De Stefano D, Carnuccio R, Maiuri M . Nanomaterials toxicity and cell death modalities. J Drug Deliv. 2013; 2012:167896. PMC: 3523142. DOI: 10.1155/2012/167896. View

14.

Conde J, Doria G, Baptista P . Noble metal nanoparticles applications in cancer. J Drug Deliv. 2011; 2012:751075. PMC: 3189598. DOI: 10.1155/2012/751075. View

15.

Vetten M, Gulumian M . Differences in uptake of 14 nm PEG-liganded gold nanoparticles into BEAS-2B cells is dependent on their functional groups. Toxicol Appl Pharmacol. 2018; 363:131-141. DOI: 10.1016/j.taap.2018.11.014. View

16.

Fobian S, Petzer M, Vetten M, Steenkamp V, Gulumian M, Cordier W . Mechanisms facilitating the uptake of carboxyl-polythene glycol-functionalized gold nanoparticles into multicellular spheroids. J Pharm Pharmacol. 2022; 74(9):1282-1295. DOI: 10.1093/jpp/rgac017. View

17.

Torrisi L . Gold nanoparticles enhancing protontherapy efficiency. Recent Pat Nanotechnol. 2015; 9(1):51-60. DOI: 10.2174/1872210509999141222224121. View

18.

Zhao Z, Ukidve A, Krishnan V, Mitragotri S . Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers. Adv Drug Deliv Rev. 2019; 143:3-21. DOI: 10.1016/j.addr.2019.01.002. View

19.

Ferreira L, Gaspar V, Mano J . Bioinstructive microparticles for self-assembly of mesenchymal stem Cell-3D tumor spheroids. Biomaterials. 2018; 185:155-173. PMC: 7617209. DOI: 10.1016/j.biomaterials.2018.09.007. View

20.

Khaitan D, Chandna S, Arya M, Dwarakanath B . Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. J Transl Med. 2006; 4:12. PMC: 1420330. DOI: 10.1186/1479-5876-4-12. View